Biogen | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 4.81B 1.54B 2024-12
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
ALKERMES USD 443.75M 333.52M 2024-12
Amgen USD 3.38B 111M 2024-12
Bayer EUR 1.83B 2.31B 2025-03
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Incyte USD 234.19M 172.64M 2025-03
Merck USD 5.22B 114M 2024-12
Moderna USD -964000000 220M 2025-03
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.53B 124M 2025-06
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sanofi EUR 2.16B 20M 2025-03
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 423.5M 27M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12


Biogen Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.